Assembly Biosciences (ASMB) Interest Expenses (2010 - 2025)

Assembly Biosciences' Interest Expenses history runs 14 years deep, the most recent figure standing at $17.2 million for Q4 2025.

• On a quarterly basis, Interest Expenses fell 91.86% year-over-year to $17.2 million in Q4 2025; TTM through Dec 2025 was $17.2 million, a 91.86% decrease from a year earlier, with the FY2025 full-year figure at $17.2 million, down 91.86% from the prior year.
• Interest Expenses slipped to $17.2 million in Q4 2025 per ASMB's latest filing, from $211.6 million in the prior quarter.
• Across five years, Interest Expenses topped out at $211.6 million in Q4 2024 and bottomed at $1000.0 in Q3 2022.
• The 5-year median for Interest Expenses is $1.0 million (2021), against an average of $22.0 million.
• Across the five-year window, Interest Expenses sank 99.99% in 2022 and soared 1113657.89% in 2024, its largest moves.
• Year by year, Interest Expenses stood at $930000.0 in 2021, then surged by 47.53% to $1.4 million in 2022, then slumped by 98.62% to $19000.0 in 2023, then surged by 1113657.89% to $211.6 million in 2024, then sank by 91.86% to $17.2 million in 2025.
• Per Business Quant, the three latest ASMB Interest Expenses figures stand at $17.2 million (Q4 2025), $211.6 million (Q4 2024), and $19000.0 (Q4 2023).